RecentNews.uk
China is increasingly functioning as a primary research and development lab for global weight-loss drugs.
Major pharmaceutical companies are leveraging local clinical trial infrastructure to accelerate pipelines.
The shift aims to address intense global demand and supply constraints for metabolic treatments.
Tap below to vote and see what others think.